Treating glioblastoma or refractory Hodgkin’s disease in the UK relies on the specific pharmacology of lomustine 40 mg, an alkylating nitrosourea. This agent is highly lipophilic, allowing it to cross the blood-brain barrier to disrupt malignant DNA replication. This "genomic intrusion" prevents tumor cells from dividing, but the mechanism is scrupulously objective regarding the risk ... https://www.oddwayinternational.com/lomustine-40-mg-capsules/